
The increased prevalence of hypertension, heart disease, diabetes, and obesity, combined with an ageing population, has led to a higher occurrence of renal diseases. Chronic kidney disease (CKD) is characterized by persistent inflammation, fibrosis, and gradual loss of renal function, resulting in renal failure. Gender significantly influences CKD incidence and progression. Epigenetic programming plays a critical role in renal injury and fibrosis. Epigenetic modifications like histone alterations and DNA methylation, which are reversible, offer potential targets for treating renal diseases. This summary explores sex-related epigenetic effects on renal fibrosis and inflammation, suggesting potential therapeutic avenues for CKD.
Like
Save
Share